Invokana Ketoacidosis Lawsuit

  • The Fee Is Free Unless You Win®.
  • America's Largest Injury Law Firm™
  • Protecting Families Since 1988
  • 20 Billion+ Won
  • 1,000+ Lawyers Nationwide

Free Case Evaluation

Tell us about your situation so we can get started fighting for you. We tailor each case to meet our clients' needs.
Results may vary depending on your particular facts and legal circumstances. ©2024 Morgan and Morgan, P.A. All rights reserved.
Our results speak for themselves

The attorneys featured above are licensed in Florida. For a full list of attorneys in your state please visit our attorney page.

Invokana Ketoacidosis Lawsuit

Note: We are no longer taking Invokana and Invokamet cases, but are still accepting cases from those injured by taking Jardiance, Xigduo XR, Farxiga, and Glyxambi.

Some patients say they have suffered serious injuries after taking SGLT2 inhibitors, a class of prescription medicines that are designed to lower blood sugar in adults suffering from type 2 diabetes. Below are examples of these medications:

  • Invokana (canagliflozin)
  • Invokamet (canagliflozin/metformin)
  • Jardiance (empagliflozin)
  • Glyxambi (empagliflozin/linagliptin)
  • Xigduo XR (dapagliflozin/metformin)
  • Farxiga (dapagliflozin)

FDA Investigating Injuries Linked to Type 2 Diabetes Medicines

In May 2015, the FDA warned that these treatments may put patients at risk for a serious health condition known as ketoacidosis, which may cause diabetic comas or death.

In a drug safety announcement, the FDA said it was investigating reports that certain type 2 diabetes drugs caused ketoacidosis. According to the American Diabetes Association, ketoacidosis – also known as acidosis or diabetic ketoacidosis (DKA) – is a condition that causes the body to produce excessive levels of blood acids, or keytones, leading to the fatal symptoms.

The FDA’s investigation reportedly came after the agency reviewed 20 adverse event reports from patients who were seriously injured or hospitalized for the condition after taking type 2 diabetes drugs, including Invokana and Invokamet. These drugs belong to a class of medications known as sodium-glucose cotransporter-2 (SGLT2) inhibitors, which have been FDA approved to lower blood sugar in adults with type 2 diabetes.

In the FDA’s announcement, the agency warned patients that they should seek immediate medical attention if they experience any symptoms of ketoacidosis, including:

  • Difficulty breathing
  • Nausea
  • Vomiting
  • Abdominal pain
  • Confusion
  • Unusual fatigue or sleepiness
Scroll down for more

How it works

It's easy to get started.
The Fee Is Freeâ„¢. Only pay if we win.

Results may vary depending on your particular facts and legal circumstances.

  • Step 1

    Submit
    your claim

    With a free case evaluation, submitting your case is easy with Morgan & Morgan.

  • Step 2

    We take
    action

    Our dedicated team gets to work investigating your claim.

  • Step 3

    We fight
    for you

    If we take on the case, our team fights to get you the results you deserve.

Client success
stories that inspire and drive change

Explore over 55,000 5-star reviews and 800 client testimonials to discover why people trust Morgan & Morgan.

Results may vary depending on your particular facts and legal circumstances. Based on Select nationwide reviews

  • Video thumbnail for 5l3q2e67j8
    Wistia video play button
  • Video thumbnail for yfe952tcop
    Wistia video play button
  • Video thumbnail for z1bqwg9hkl
    Wistia video play button
  • Video thumbnail for s5nb3hnvkv
    Wistia video play button
  • Video thumbnail for t4elibxene
    Wistia video play button
  • Video thumbnail for 5nr9efxqj3
    Wistia video play button
  • Video thumbnail for e8s1x6u5jp
    Wistia video play button